US2012065371A1PendingUtilityA1

Recombinant proteins from filoviruses and their use

Assignee: LEHRER AXEL THOMASPriority: Oct 7, 2005Filed: Apr 4, 2011Published: Mar 15, 2012
Est. expiryOct 7, 2025(expired)· nominal 20-yr term from priority
A61K 2039/55566C12N 2760/14122A61K 2039/55577A61K 39/12C12N 2760/14134C12N 2760/14234C07K 14/005C12N 2760/14222
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Filovirus subunit protein immunogens are produced using a recombinant expression system and combined with one or more adjuvants in immunogenic formulations. The subunit proteins include GP95, GP-FL, VP40, VP24, and NP derived from Ebola Virus and Marburg Virus. Adjuvants include saponins, emulsions, alum, and dipeptidyl peptidase inhibitors. The disclosed immunogenic formulations are effective in inducing strong antibody responses directed against individual Filovirus proteins and intact Filovirus particles as well as stimulating cell-mediated immune responses to the Filoviruses.

Claims

exact text as granted — not AI-modified
1 .- 22 . (canceled) 
     
     
         23 . An immunogenic composition comprising a recombinant Filovirus VP40 protein subunit, wherein the protein subunit is expressed and secreted as a soluble protein from stably transformed insect cells. 
     
     
         24 . An immunogenic composition comprising a recombinant Filovirus VP24 protein subunit, wherein the protein subunit is expressed and secreted as a soluble protein from stably transformed insect cells. 
     
     
         25 . An immunogenic composition comprising a recombinant Filovirus NP protein subunit, wherein the protein subunit is expressed and secreted as a soluble protein from stably transformed insect cells. 
     
     
         26 .- 49 . (canceled)

Join the waitlist — get patent alerts

Track US2012065371A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.